Stem cell therapy for cardiac regeneration: key points

Kyryk Vitalii

doi:10.22494/cot.v12i1.160

Cell and Organ Transplantology. 2024; 12(1):4-21.
DOI: 10.22494/cot.v12i1.160

Stem cell therapy for cardiac regeneration: key points

Kyryk V.

Institute of Genetic and Regenerative Medicine, M. D. Strazhesko National Scientific Center of Cardiology, Clinical and Regenerative Medicine, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
D. F. Chebotarev State Institute of Gerontology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine

Abstract

Cardiovascular diseases are a leading cause of disability and mortality among the working population, necessitating the development and implementation of new, more effective treatment and rehabilitation methods for such patients, including the use of modern cell and tissue technologies.
In this review, an analysis and summary of research results over the past decades regarding the effectiveness of various types of stem cells in heart pathology were conducted.
Priority directions include the search for more accessible and safe sources of stem cells, the development of new effective methods for their cultivation, and the use of scaffolds for transplantation. Given the pathogenetic mechanisms of cardiovascular pathology and myocardial regeneration, particular interest for clinical application is drawn to tissue-specific progenitors from the myocardium for replacing injured cardiomyocytes, endothelial progenitors for correcting accompanying endothelial dysfunction, and multipotent mesenchymal cells of various origins with low immunogenicity that exhibit trophic, anti-inflammatory, immunomodulatory, and anti-apoptotic effects. Questions regarding the optimal method, dose, and frequency of stem cell administration, as well as the standardization of criteria for their quality and effectiveness, remain open. Additionally, the combined use of different types of stem cells may serve as a new priority strategy in assessing the effectiveness and safety of cell therapy, especially considering the paradigm of repeated transplantation.
The successful translation of obtained preclinical results into further large, well-planned, placebo-controlled clinical trials will enhance the safety and effectiveness of cell therapy for cardiovascular diseases, which is one of the current challenges of modern regenerative medicine.

Keywords: cardiovascular diseases; cardiac regeneration; stem cells; cell therapy; preclinical studies; clinical trials

Full Text PDF

References

1. Abouzid MR, Ali K, Kamel I, Esteghamati S, Saleh A, Ghanim M. The Safety and Efficacy of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Patients With Heart Failure and Myocardial Infarction: A Meta-Analysis of Clinical Trials. Cureus. 2023 Nov 29;15(11):e49645. Available from: https://doi.org/10.7759/cureus.49645 https://doi.org/10.7759/cureus.49645 PMid:38033439 PMCid:PMC10686683

2. Alam P, Maliken BD, Jones SM, Ivey MJ, Wu Z, Wang Y, Kanisicak O. Cardiac remodeling and repair: recent approaches, advancements, and future perspective. Int J Mol Sci. 2021;22(23):13104. Available from: https://doi.org/10.3390/ijms222313104 https://doi.org/10.3390/ijms222313104 PMid:34884909 PMCid:PMC8658114

3. Amini M, Zayeri F, Salehi M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study. BMC Public Health. 2017; 21:401(2021). Available from: https://doi.org/10.1186/s12889-021-10429-0 https://doi.org/10.1186/s12889-021-10429-0 PMid:33632204 PMCid:PMC7905904

4. Assmus B, Fischer-Rasokat U, Honold J, Seeger FH, Fichtlscherer S, Tonn T, et al. TOPCARE-CHD Registry. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circ Res. 2007 Apr 27;100(8):1234-41. Available from: https://doi.org/10.1161/01.RES.0000264508.47717.6b https://doi.org/10.1161/01.RES.0000264508.47717.6b PMid:17379833

5. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002; 106:3009-3017. Available from: https://doi.org/10.1161/01.cir.0000043246.74879.cd https://doi.org/10.1161/01.CIR.0000043246.74879.CD PMid:12473544

6. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004 Apr 8;428(6983):668-73. Available from: https://doi.org/10.1038/nature02460 https://doi.org/10.1038/nature02460 PMid:15034594

7. Barbash IM, Chouraqui P, Baron J, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003; 108(7):863-868. Available from: https://doi.org/10.1161/01.CIR.0000084828.50310.6A https://doi.org/10.1161/01.CIR.0000084828.50310.6A PMid:12900340

8. Barik P, Shibu MA, Hsieh DJ, Day CH, Chen RJ, Kuo WW, et al. Cardioprotective effects of transplanted adipose-derived stem cells under Ang II stress with Danggui administration augments cardiac function through upregulation of insulin-like growth factor 1 receptor in late-stage hypertension rats. Environ Toxicol. 2021 Jul;36(7):1466-1475. Available from: https://doi.org/10.1002/tox.23145 https://doi.org/10.1002/tox.23145 PMid:33881220

9. Bartolucci J, Verdugo FJ, González PL, Larrea RE, Abarzua E, Goset C, et al. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]). Circ Res. 2017 Oct 27;121(10):1192-1204. Available from: https://doi.org/10.1161/CIRCRESAHA.117 https://doi.org/10.1161/CIRCRESAHA.117.310712 PMid:28974553 PMCid:PMC6372053

10. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 2001 Jun 7;344(23):1750-7. Available from: https://doi.org/10.1056/NEJM200106073442303 https://doi.org/10.1056/NEJM200106073442303 PMid:11396441

11. Bischoff R. Regeneration of single skeletal muscle fibers in vitro. Anat Rec. 1975; 182(2):215-35. Available from: https://doi.org/10.1002/ar.1091820207 https://doi.org/10.1002/ar.1091820207 PMid:168794

12. Blum KM, Mirhaidari GJM, Breuer CK. Tissue engineering: Relevance to neonatal congenital heart disease. Semin Fetal Neonatal Med. 2022;27(1):101225. Available from: https://doi.org/10.1016/j.siny.2021.101225 https://doi.org/10.1016/j.siny.2021.101225 PMid:33674254 PMCid:PMC8390581

13. Bolli R, Chugh AR, D’Amario D, et al. Effect of Cardiac Stem Cells in Patients with Ischemic Cardiomyopathy: Initial Results of the SCIPIO Trial. Lancet. 2011;378(9806):1847-1857. Available from: https://doi.org/10.1016/s0140-6736(11)61590-0 https://doi.org/10.1016/S0140-6736(11)61590-0 PMid:22088800

14. Bolli R, Hare JM, March KL, Pepine CJ, Willerson JT, Perin EC, et al. Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure). Circ Res. 2018 Jun 8;122(12):1703-1715. Available from: https://doi.org/10.1161/CIRCRESAHA.118.312978 https://doi.org/10.1161/CIRCRESAHA.118.312978 PMid:29703749 PMCid:PMC5993622

15. Bolli R, Mitrani RD, Hare JM, Pepine CJ, Perin EC, Willerson JT, et al. A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial. Eur J Heart Fail. 2021 Apr;23(4):661-674. Available from: https://doi.org/10.1002/ejhf.2178 https://doi.org/10.1002/ejhf.2178 PMid:33811444 PMCid:PMC8357352

16. Bolli R, Tang XL, Sanganalmath SK, Rimoldi O, Mosna F, Abdel-Latif A, et al. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation. 2013; 128(2):122-31. Available from: https://doi.org/10.1161/circulationaha.112.001075 https://doi.org/10.1161/CIRCULATIONAHA.112.001075 PMid:23757309 PMCid:PMC3807652

17. Bolli R. Repeated cell therapy: a paradigm shift whose time has come. Circ Res. 2017; 120(7):1072-1074. Available from: https://doi.org/10.1161/circresaha.117.310710 https://doi.org/10.1161/CIRCRESAHA.117.310710 PMid:28179431 PMCid:PMC5384469

18. Bollini S, Silini AR, Banerjee A, Wolbank S, Balbi C, Parolini O. Cardiac Restoration Stemming From the Placenta Tree: Insights From Fetal and Perinatal Cell Biology. Front Physiol. 2018 Apr 11;9:385. Available from: https://doi.org/10.3389/fphys.2018.00385 https://doi.org/10.3389/fphys.2018.00385 PMid:29695981 PMCid:PMC5904405

19. Boncoraglio GB, Ranieri M, Bersano A, Parati EA, Del Giovane C. Stem cell transplantation for ischemic stroke. Cochrane Database Syst Rev. 2019; 5(5):CD007231. Available from: https://doi.org/10.1002/14651858.CD007231 https://doi.org/10.1002/14651858.CD007231

20. Boukouaci W, Lauden L, Siewiera J, et al. Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistence. Cardiovasc Res. 2014;104(2):290-302. Available from: https://doi.org/10.1093/cvr/cvu208 https://doi.org/10.1093/cvr/cvu208 PMid:25213554

21. Bruun K, Schermer E, Sivendra A, Valaik E, Wise RB, Said R, et al. Therapeutic applications of adipose-derived stem cells in cardiovascular disease. Am J Stem Cells. 2018;7(4):94-103. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261868

22. Cağavi E, Koз A, Şahoğlu Gцktaş S. The heart of the matter: cardiac stem cells. Turk J Biol. 2016; 40(5):968-980: Available from: https://doi.org/10.3906/biy-1602-63 https://doi.org/10.3906/biy-1602-63

23. Cambria E, Pasqualini FS, Wolint P, Günter J Steiger J, Bopp A, et al. Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types. npj Regen Med 2017; 2:17. Available from: https://doi.org/10.1038/s41536-017-0024-1 https://doi.org/10.1038/s41536-017-0024-1 PMid:29302353 PMCid:PMC5677990

24. Can A, Ulus AT, Cinar O, Topal Celikkan F, Simsek E, Akyol M, et al. Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting. Stem Cell Rev Rep. 2015 Oct;11(5):752-60. Available from: https://doi.org/10.1007/s12015-015-9601-0 https://doi.org/10.1007/s12015-015-9601-0 PMid:26123356

25. Cantero Peral S, Burkhart HM, Oommen S, Yamada S, Nyberg SL, Li X, et al. Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system. Stem Cells Transl Med. 2015; 4(2):195-206. Available from: https://doi.org/10.5966/sctm.2014-0195 https://doi.org/10.5966/sctm.2014-0195 PMid:25561683 PMCid:PMC4303361

26. Caplan AI. Molecular and cellular differentiation of muscle, cartilage, and bone in the developing limb. Prog Clin Biol Res. 1986; 217(B):307-318.

27. Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A, et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol. 2007 Nov 6;50(19):1884-93. Available from: https://doi.org/10.1016/j.jacc.2007.07.054 https://doi.org/10.1016/j.jacc.2007.07.054 PMid:17980256

28. Chakravarty T, Henry TD, Kittleson M, Lima J, Siegel RJ, Slipczuk L, et al. Allogeneic cardiosphere-derived cells for the treatment of heart failure with reduced ejection fraction: the Dilated cardiomYopathy iNtervention with Allogeneic MyocardIally-regenerative Cells (DYNAMIC) trial. EuroIntervention. 2020 Jul 17;16(4):e293-e300. Available from: https://doi.org/10.4244/EIJ-D-19-00035 https://doi.org/10.4244/EIJ-D-19-00035 PMid:31763984

29. Chan HH, Meher Homji Z, Gomes RS, Sweeney D, Thomas GN, Tan JJ, et al. Human cardiosphere-derived cells from patients with chronic ischaemic heart disease can be routinely expanded from atrial but not epicardial ventricular biopsies. J Cardiovasc Transl Res. 2012; 5(5):678-87. Available from: https://doi.org/10.1007/s12265-012-9389-0 https://doi.org/10.1007/s12265-012-9389-0 PMid:22752803 PMCid:PMC3447135

30. Chen HJ, Chen CH, Chang MY, Tsai DC, Baum EZ, Hariri R, et al. Human placenta-derived adherent cells improve cardiac performance in mice with chronic heart failure. Stem Cells Transl Med. 2015;4(3):269-75. Available from: https://doi.org/10.5966/sctm.2014-0135 https://doi.org/10.5966/sctm.2014-0135 PMid:25673767 PMCid:PMC4339850

31. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004; 94(1):92-95. Available from: https://doi.org/10.1016/j.amjcard.2004.03.034 https://doi.org/10.1016/j.amjcard.2004.03.034 PMid:15219514

32. Chen Y, Shen H, Ding Y, Yu Y, Shao L, Shen Z. The application of umbilical cord-derived MSCs in cardiovascular diseases. J Cell Mol Med. 2021 Sep;25(17):8103-8114. Available from: https://doi.org/10.1111/jcmm.16830 https://doi.org/10.1111/jcmm.16830 PMid:34378345 PMCid:PMC8419197

33. Chimenti I, Gaetani R, Forte E, Angelini F, De Falco E, Zoccai GB, et al. Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture. J Cell Mol Med. 2014; 18(4):624-34. Available from: https://doi.org/10.1111/jcmm.12210 https://doi.org/10.1111/jcmm.12210 PMid:24444305 PMCid:PMC4000114

34. Chiu RC, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995; 60(1):12-18. https://doi.org/10.1016/S0003-4975(95)00374-6 PMid:7598572

35. Ciccocioppo R, Klersy C, Leffler DA, Rogers R, Bennett D, Corazza GR. Systematic review with meta-analysis: Safety and efficacy of local injections of mesenchymal stem cells in perianal fistulas. JGH Open. 2019;3(3):249-260. Available from: https://doi.org/10.1002/jgh3.12141 https://doi.org/10.1002/jgh3.12141 PMid:31276044 PMCid:PMC6586577

36. ClinicalTrials.gov database. Available from: http://www.clinicaltrials.gov.

37. Correia CD, Ferreira A, Fernandes MT, Silva BM, Esteves F, Leitão HS, et al. Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications-Are We on the Road to Success? Cells. 2023 Jun 27;12(13):1727. Available from: https://doi.org/10.3390/cells12131727 https://doi.org/10.3390/cells12131727 PMid:37443761 PMCid:PMC10341347

38. D’Amario D, Fiorini C, Campbell PM, Goichberg P, Sanada F, Zheng H, et al. Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res. 2011; 108(7):857-861. Available from: https://doi.org/ https://doi.org/10.1161/CIRCRESAHA.111.241380 PMid:21330601 PMCid:PMC3074470

39. de Castro LL, Lopes-Pacheco M, Weiss DJ, Cruz FF, Rocco PRM. Current understanding of the immunosuppressive properties of mesenchymal stromal cells. J Mol Med (Berl). 2019;97(5):605-618. Available from: https://doi.org/10.1007/s00109-019-01776-y https://doi.org/10.1007/s00109-019-01776-y PMid:30903229

40. de Jong R, Houtgraaf JH, Samiei S, Boersma E, Duckers HJ. Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials. Circ Cardiovasc Interv. 2014;7(2):156-67. Available from: https://doi.org/10.1161/CIRCINTERVENTIONS.113.001009 https://doi.org/10.1161/CIRCINTERVENTIONS.113.001009 PMid:24668227

41. Deinsberger J, Reisinger D, Weber B. Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis. NPJ Regen Med. 2020;5:15. Available from: https://doi.org/10.1038/s41536-020-00100-4 https://doi.org/10.1038/s41536-020-00100-4 PMid:32983575 PMCid:PMC7486930

42. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7. Available from: https://doi.org/10.1080/14653240600855905 https://doi.org/10.1080/14653240600855905 PMid:16923606

43. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000;109(1):235-42. https://doi.org/10.1046/j.1365-2141.2000.01986.x PMid:10848804

44. Fanton Y, Robic B, Rummens JL, Daniëls A, Windmolders S, Willems L, et al. Cardiac atrial appendage stem cells engraft and differentiate into cardiomyocytes in vivo: A new tool for cardiac repair after MI. Int J Cardiol. 2015;201:10-9. Available from: https://doi.org/10.1016/j.ijcard.2015.07.066 https://doi.org/10.1016/j.ijcard.2015.07.066 PMid:26285182

45. Fernández-Avilés F, Sanz-Ruiz R, Bogaert J, Casado Plasencia A, Gilaberte I, Belmans A, et al. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction. Circ Res. 2018 Aug 17;123(5):579-589. Available from: https://doi.org/10.1161/CIRCRESAHA.118.312823 https://doi.org/10.1161/CIRCRESAHA.118.312823 PMid:29921651

46. Fisher SA, Brunskill SJ, Doree C, Mathur A, Taggart DP, Martin-Rendon E. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst Rev. 2014; 4:CD007888. Available from: https://doi.org/10.1002/14651858.CD007888.pub2 https://doi.org/10.1002/14651858.CD007888.pub2

47. Fisher SA, Zhang H, Doree C, Mathur A, Martin-Rendon E. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2015; 2015(9):CD006536. Available from: http://doi.org/10.1002/14651858.CD006536 https://doi.org/10.1002/14651858.CD006536

48. Fouts K, Fernandes B, Mal N, Liu J, Laurita KR. Electrophysiological consequence of skeletal myoblast transplantation in normal and infarcted canine myocardium. Heart Rhythm. 2006; 3(4):452-461. https://doi.org/10.1016/j.hrthm.2005.12.016 PMid:16567294

49. Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol. 2001; 37(6):1726-1732. Available from: https://doi.org/ https://doi.org/10.1016/S0735-1097(01)01200-1 PMid:11345391

50. Gabrielyan AV, Yakushev AB, Matyashchuk AS, Domanskiy TM, Kudlay IV, Romanova SV, Shymova AYu. Сhanges of intracardiac hemodynamics in patients with decreased myocardial contractility at transplantation of cord blood stem cells. Cell and Organ Transplantology. 2015; 3(1):24-27. Available from: https://doi.org/10.22494/COT.V3I1.26 https://doi.org/10.22494/COT.V3I1.26

51. Gabriyelian АВ, Голюк ЄЛ, Домбровський ДБ, Кирик ВМ, Медведєв ВВ, Руденко СА, Шаблій ВА. Новітні методи застосування стовбурових клітин і біоінженерних технологій у регенеративній медицині. Реф. роботи, удостоєної Національної премії України ім. Бориса Патона, Київ, 2021 р. http://www.kdpu-nt.gov.ua/sites/default/files/work_files/4_referat_2.pdf

52. Gao LR, Chen Y, Zhang NK, Yang XL, Liu HL, Wang ZG, et al. Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial. BMC Med. 2015 Jul 10;13:162. Available from: https://doi.org/10.1186/s12916-015-0399-z https://doi.org/10.1186/s12916-015-0399-z PMid:26162993 PMCid:PMC4499169

53. Giedrimiene D, King R. Burden of cardiovascular disease (CVD) on economic cost. Comparison of outcomes in US and Europe. Circulation: Cardiovascular Quality and Outcomes. 2017;10:A207. Available from: https://doi.org/10.1161/circoutcomes.10.suppl_3.207 https://doi.org/10.1161/circoutcomes.10.suppl_3.207

54. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28-e292. Available from: https://doi.org/10.1161/01.cir.0000441139.02102.80 https://doi.org/10.1161/01.cir.0000441139.02102.80

55. Guo R, Morimatsu M, Feng T, Lan F, Chang D, Wan F, Ling Y. Stem cell-derived cell sheet transplantation for heart tissue repair in myocardial infarction. Stem Cell Res Ther. 2020 Jan 8;11(1):19. Available from: https://doi.org/10.1186/s13287-019-1536-y https://doi.org/10.1186/s13287-019-1536-y PMid:31915074 PMCid:PMC6950817

56. Guo Y, Wysoczynski M, Nong Y, Tomlin A, Zhu X, Gumpert AM, et al. Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction. Basic Res Cardiol. 2017 Mar;112(2):18. Available from: https://doi.org/10.1007/s00395-017-0606-5 https://doi.org/10.1007/s00395-017-0606-5 PMid:28210871 PMCid:PMC5655998

57. Haack-Sørensen M, Friis T, Mathiasen AB, Jørgensen E, Hansen L, Dickmeiss E, et al. Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up. Cell Transplant. 2013;22(3):521-8. Available from: https://doi.org/10.3727/096368912X636830 https://doi.org/10.3727/096368912X636830 PMid:22472086

58. Hare JM, DiFede DL, Rieger AC, Florea V, Landin AM, El-Khorazaty J, et al. Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy: POSEIDON-DCM Trial. J Am Coll Cardiol. 2017;69:526-37. Available from: https://doi.org/10.1016/j.jacc.2016.11.009 https://doi.org/10.1016/j.jacc.2016.11.009 PMid:27856208 PMCid:PMC5291766

59. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (Prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009;54(24):2277-86. Available from: https://doi.org/10.1016/j.jacc.2009.06.055 https://doi.org/10.1016/j.jacc.2009.06.055 PMid:19958962 PMCid:PMC3580848

60. Hatzistergos KE, Quevedo H, Oskouei BN, Hu Q, Feigenbaum GS, Margitich IS, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res. 2010; 107(7):913-922. https://doi.org/10.1161/CIRCRESAHA.110.222703 PMid:20671238 PMCid:PMC3408082

61. He JQ, Vu DM, Hunt G, et al. Human cardiac stem cells isolated from atrial appendages stably express c-kit. PLoS One. 2011; 6(11):e27719. https://doi.org/10.1371/journal.pone.0027719 PMid:22140461 PMCid:PMC3225366

62. Heldman AW, DiFede DL, Fishman JE, Zambrano JP, Trachtenberg BH, Karantalis V, et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA. 2014 Jan 1;311(1):62-73. Available from: https://doi.org/10.1001/jama.2013.282909 https://doi.org/10.1001/jama.2013.282909 PMid:24247587 PMCid:PMC4111133

63. Henning RJ, Abu-Ali H, Balis JU, Morgan MB, Willing AE, Sanberg PR. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant. 2004; 13(7-8):729-739. https://doi.org/10.3727/000000004783983477 PMid:15690974

64. Henry TD, Pepine CJ, Lambert CR, Traverse JH, Schatz R, Costa M, et al. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction. Catheter Cardiovasc Interv. 2017; 89(2):169-177. Available from: https://doi.org/10.1002/ccd.26601 https://doi.org/10.1002/ccd.26601 PMid:27148802

65. Hirata Y, Sata M, Motomura N, Takanashi M, Suematsu Y, Ono M, Takamoto S. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem Biophys Res Commun. 2005; 327(2):609-614. https://doi.org/10.1016/j.bbrc.2004.12.044 PMid:15629157

66. Hong KU, Guo Y, Li QH, Cao P, Al-Maqtari T, Vajravelu BN, et al. c-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart. PLoS One. 2014;9:e96725. Available from: https://doi.org/10.1371/journal.pone.0096725 https://doi.org/10.1371/journal.pone.0096725 PMid:24806457 PMCid:PMC4013035

67. Hong KU, Li QH, Guo Y, Patton NS, Moktar A, Bhatnagar A, Bolli R. A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice. Basic Res Cardiol. 2013, 108:346. Available from: https://doi.org/10.1007/s00395-013-0346-0. https://doi.org/10.1007/s00395-013-0346-0 PMid:23549981 PMCid:PMC3684056

68. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy, 2005. 7(5):393-395. Available from: https://doi.org/10.1080/14653240500319234 https://doi.org/10.1080/14653240500319234 PMid:16236628

69. Houtgraaf JH, den Dekker WK, van Dalen BM, Springeling T, de Jong R, van Geuns RJ, et al. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2012;59(5):539-40. Available from: http://doi.org/10.1016/j.jacc.2011.09.065 https://doi.org/10.1016/j.jacc.2011.09.065 PMid:22281257

70. Huang H, Huang W. Regulation of endothelial progenitor cell functions in ischemic heart disease: new therapeutic targets for cardiac remodeling and repair. Front Cardiovasc Med. 2022;9:896782. Available from: https://doi.org/10.3389/fcvm.2022.896782 https://doi.org/10.3389/fcvm.2022.896782 PMid:35677696 PMCid:PMC9167961

71. Hutchings G, Janowicz K, Moncrieff L, Dompe C, Strauss E, Kocherova I, et al. The proliferation and differentiation of adipose-derived stem cells in neovascularization and angiogenesis. Int J Mol Sci. 2020;21(11):3790. Available from: https://doi.org/10.3390/ijms21113790 https://doi.org/10.3390/ijms21113790 PMid:32471255 PMCid:PMC7312564

72. Hwangbo S, Kim J, Her S, Cho H, Lee J. Therapeutic potential of human adipose stem cells in a rat myocardial infarction model. Yonsei Med J. 2010 Jan;51(1):69-76. doi: 10.3349/ymj.2010.51.1.69 https://doi.org/10.3349/ymj.2010.51.1.69 PMid:20046516 PMCid:PMC2799983

73. Ichim TE, Solano F, Brenes R, Glenn E, Chang J, Chan K, et al. Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy. Reprod Biomed Online. 2008;16(6):898-905. Available from: https://doi.org/10.1016/s1472-6483(10)60159-9 https://doi.org/10.1016/S1472-6483(10)60159-9 PMid:18549704

74. Ilic D, Ogilvie C. Concise review: Human embryonic stem cells-what have we done? What are we doing? Where are we going? Stem Cells. 2017;35(1):17-25. Available from: https://doi.org/10.1002/stem.2450 https://doi.org/10.1002/stem.2450 PMid:27350255

75. Ishigami S, Sano T, Krishnapura S, Ito T, Sano S. An overview of stem cell therapy for paediatric heart failure. Eur J Cardiothorac Surg. 2020; 58(5):881-887. Available from: https://doi.org/10.1093/ejcts/ezaa155 https://doi.org/10.1093/ejcts/ezaa155 PMid:32588055

76. Itzhaki-Alfia A, Leor J. Resident Cardiac Progenitor Cells. 2014. Available from: https://doi.org/10.1007/978-94-017-8657-7_2. https://doi.org/10.1007/978-94-017-8657-7_2

77. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation. 2012;126(5):551-68.Available from: https://doi.org/10.1161/CIRCULATIONAHA.111.086074 https://doi.org/10.1161/CIRCULATIONAHA.111.086074 PMid:22730444 PMCid:PMC4282649

78. Joo HS, Suh JH, Lee HJ, Bang ES, Lee JM. Current knowledge and future perspectives on mesenchymal stem cell-derived exosomes as a new therapeutic agent. Int J Mol Sci. 2020;21(3):727. Available from: https://doi.org/10.3390/ijms21030727 https://doi.org/10.3390/ijms21030727 PMid:31979113 PMCid:PMC7036914

79. Kajstura J, Rota M, Cappetta D, Ogórek B, Arranto C, Bai Y, et al. Cardiomyogenesis in the aging and failing human heart. Circulation. 2012 Oct 9;126(15):1869-81. Available from: https://doi.org/10.1161/CIRCULATIONAHA.112.118380 https://doi.org/10.1161/CIRCULATIONAHA.112.118380 PMid:22955965 PMCid:PMC3477474

80. Kanazawa H, Malliaras K, Yee K, Tseliou E., Marbán L., Makkar R., Marbánet E. Comparison of cardiac engraftment with two catheter-based delivery methods: catheter-mediated intramyocardial delivery outperforms intracoronary delivery of cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation. 2011; Abstract 124:A16466. https://doi.org/10.1161/circ.124.suppl_21.A16466

81. Kanisicak O, Vagnozzi RJ, Molkentin JD. Identity crisis for regenerative cardiac cKit+ cells. Circ Res. 2017;121(10):1130-2. Available from: https://doi.org/10.1161/CIRCRESAHA.117.311921 https://doi.org/10.1161/CIRCRESAHA.117.311921 PMid:29074532 PMCid:PMC5687275

82. Kara RJ, Bolli P, Karakikes I, Matsunaga I, Tripodi J, Tanweer O, et al. Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation. Circ Res. 2012;110(1):82-93. Available from: https://doi.org/10.1161/CIRCRESAHA.111.249037 https://doi.org/10.1161/CIRCRESAHA.111.249037 PMid:22082491 PMCid:PMC3365532

83. Kawaguchi S, Soma Y, Nakajima K, Kanazawa H, Tohyama S, Tabei R, et al. Intramyocardial Transplantation of Human iPS Cell-Derived Cardiac Spheroids Improves Cardiac Function in Heart Failure Animals. JACC Basic Transl Sci. 2021 Feb 19;6(3):239-254. Available from: https://doi.org/10.1016/j.jacbts.2020.11.01 https://doi.org/10.1016/j.jacbts.2020.11.017 PMid:33778211 PMCid:PMC7987543

84. Kawamoto A, Gwon HC, Iwaguro H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001; 103(5):634-637. https://doi.org/10.1161/01.CIR.103.5.634 PMid:11156872

85. Kawamura T, Ito Y, Ito E, Takeda M, Mikami T, Taguchi T, et al. Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports. Front Cardiovasc Med. 2023 Sep 15;10:1182209. Available from: https://doi.org/10.3389/fcvm.2023.1182209 https://doi.org/10.3389/fcvm.2023.1182209 PMid:37781295 PMCid:PMC10540447

86. Kitsuka T, Takahashi F, Reinhardt J, Watanabe T, Ulziibayar A, Yimit A, et al. Advances in Cardiac Tissue Engineering. Bioengineering (Basel). 2022 Nov 16;9(11):696. Available from: https://doi.org/10.3390/bioengineering9110696 https://doi.org/10.3390/bioengineering9110696 PMid:36421097 PMCid:PMC9687338

87. Koninckx R, Daniëls A, Windmolders S, Mees U, Macianskiene R, Mubagwa K, et al. The cardiac atrial appendage stem cell: a new and promising candidate for myocardial repair. Cardiovasc Res. 2013; 97(3):413-23. Available from: https://doi.org/10.1093/cvr/cvs427 https://doi.org/10.1093/cvr/cvs427 PMid:23257022

88. Krause M, Phan TG, Ma H, Sobey CG, Lim R. Cell-based therapies for stroke: are we there yet? Front Neurol. 2019;10:656. Available from: https://doi.org/10.3389/fneur.2019.00656 https://doi.org/10.3389/fneur.2019.00656 PMid:31293500 PMCid:PMC6603096

89. Kumar M, Kasala ER, Bodduluru LN, Dahiya V, Sharma D, Kumar V, et al. Animal models of myocardial infarction: Mainstay in clinical translation. Regul Toxicol Pharmacol. 2016; 76:221-30. Available from: http://doi.org/10.1016/j.yrtph.2016.03.005 https://doi.org/10.1016/j.yrtph.2016.03.005 PMid:26988997

90. Kyryk V, Ustymenko A. Isolation and phenotyping of cardiac-derived progenitor cells from neonatal mice. Cell Organ Transpl. 2021; 9(2):126-133. Available from: https://doi.org/10.22494/cot.v9i2.125 https://doi.org/10.22494/cot.v9i2.125

91. Lauden L, Boukouaci W, Borlado LR, López IP, Sepúlveda P, Tamouza R, et al. Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1. Circ Res. 2013;112(3):451-64. Available from: https://doi.org/10.1161/CIRCRESAHA.112.276501 https://doi.org/10.1161/CIRCRESAHA.112.276501 PMid:23243206

92. Lee HW, Lee HC, Park JH, Kim BW, Ahn J, Kim JH, et al. Effects of intracoronary administration of autologous adipose tissue-derived stem cells on acute myocardial infarction in a porcine model. Yonsei Med J. 2015; 56(6):1522-9. Available from: https://doi.org/10.3349/ymj.2015.56.6.1522 https://doi.org/10.3349/ymj.2015.56.6.1522 PMid:26446632 PMCid:PMC4630038

93. Lee SR, Lee SH, Moon JY, Park JY, Lee D, Lim SJ, et al. Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney model. Ren Fail. 2010; 32(7):840-848. https://doi.org/10.3109/0886022X.2010.494803 PMid:20662698

94. Leistner DM, Fischer-Rasokat U, Honold J, Seeger FH, Schächinger V, Lehmann R, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy. Clin Res Cardiol. 2011; 100(10):925-34. Available from: http://doi.org/10.1007/s00392-011-0327-y https://doi.org/10.1007/s00392-011-0327-y PMid:21633921

95. Léobon B, Roncalli J, Joffre C, Mazo M, Boisson M, Barreau C, Calise D, Arnaud E, André M, Pucéat M, Pénicaud L, Prosper F, Planat-Bénard V, Casteilla L. Adipose-derived cardiomyogenic cells: in vitro expansion and functional improvement in a mouse model of myocardial infarction. Cardiovasc Res. 2009 Sep 1;83(4):757-67. doi: 10.1093/cvr/cvp167 https://doi.org/10.1093/cvr/cvp167 PMid:19505931

96. Leong YY, Ng WH, Ellison-Hughes GM, Tan JJ. Cardiac stem cells for myocardial regeneration: they are not alone. Front Cardiovasc Med. 2017;4:47. Available from: http://doi.org/10.3389/fcvm.2017.00047 https://doi.org/10.3389/fcvm.2017.00047 PMid:28770214 PMCid:PMC5511846

97. Li L, Xia Y. Study of adipose tissue-derived mesenchymal stem cells transplantation for rats with dilated cardiomyopathy. Ann Thorac Cardiovasc Surg. 2014; 20(5):398-406. Available from: http://doi.org/10.5761/atcs.oa.13-00104 https://doi.org/10.5761/atcs.oa.13-00104 PMid:24492176

98. Li Q, Guo Y, Ou Q, Chen N, Wu WJ, Yuan F, et al. Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models. Basic Res Cardiol. 2011; 106(5):849-864. https://doi.org/10.1007/s00395-011-0180-1 PMid:21516491 PMCid:PMC3640450

99. Li Z, Solomonidis EG, Meloni M, Taylor RS, Duffin R, Dobie R, et al. Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction. Eur Heart J. 2019; 40:2507-2520. Available from: https://doi.org/10.1093/eurheartj/ehz305 https://doi.org/10.1093/eurheartj/ehz305 PMid:31162546 PMCid:PMC6685329

100. Lim M, Wang W, Liang L, Han ZB, Li Z, Geng J, et al. Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction. Stem Cell Res Ther. 2018 May 11;9(1):129. Available from: https://doi.org/10.1186/s13287-018-0888-z https://doi.org/10.1186/s13287-018-0888-z PMid:29751831 PMCid:PMC5948807

101. Lin YC, Leu S, Sun CK, Yen CH, Kao YH, Chang LT, Tsai TH, Chua S, Fu M, Ko SF, Wu CJ, Lee FY, Yip HK. Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy. J Transl Med. 2010 Sep 26;8:88. doi: 10.1186/1479-5876-8-88 https://doi.org/10.1186/1479-5876-8-88 PMid:20868517 PMCid:PMC2956711

102. Liu CB, Huang H, Sun P, Ma SZ, Liu AH, Xue J, et al. Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia. Stem Cells Transl Med. 2016 Aug;5(8):1004-13. Available from: https://doi.org/10.5966/sctm.2015-0298 https://doi.org/10.5966/sctm.2015-0298 PMid:27334487 PMCid:PMC4954453

103. Liu J, Liang X, Li M, Lin F, Ma X, Xin Y, et al. Intramyocardial injected human umbilical cord-derived mesenchymal stem cells (HucMSCs) contribute to the recovery of cardiac function and the migration of CD4+ T cells into the infarcted heart via CCL5/CCR5 signaling. Stem Cell Res Ther. 2022 Jun 11;13(1):247. Available from: https://doi.org/10.1186/s13287-022-02914-z https://doi.org/10.1186/s13287-022-02914-z PMid:35690805 PMCid:PMC9188247

104. Liu M, Lei H, Dong P, Fu X, Yang Z, Yang Y, et al. Adipose-derived mesenchymal stem cells from the elderly exhibit decreased migration and differentiation abilities with senescent properties. Cell Transplantation. 2017; 26(9):1505-1519. Available from: https://doi.org/10.1177/0963689717721221 https://doi.org/10.1177/0963689717721221 PMid:29113467 PMCid:PMC5680952

105. Liu YW, Su CT, Yen CY, Lin LJ, Hsieh PC. Arrhythmogenesis: a roadblock to cardiac stem cell therapy. Curr Treat Options Cardiovasc Med. 2016;18(10):61. Available from: http://doi.org/10.1007/s11936-016-0481-7 https://doi.org/10.1007/s11936-016-0481-7 PMid:27566708

106. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. 1999; 103(5):697-705. https://doi.org/10.1172/JCI5298 PMid:10074487 PMCid:PMC408125

107. Mallapaty S. Revealed: two men in China were first to receive pioneering stem-cell treatment for heart disease. Nature. 2020;. 581:249-250. Available from: https://doi.org/10.1038/d41586-020-01285-w https://doi.org/10.1038/d41586-020-01285-w PMid:32405042

108. Malliaras K, Li TS, Luthringer D, Terrovitis J, Cheng K, Chakravarty T, et al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation. 2012;125(1):100-12. Available from: https://doi.org/10.1161/CIRCULATIONAHA.111.042598 https://doi.org/10.1161/CIRCULATIONAHA.111.042598 PMid:22086878 PMCid:PMC3256094

109. Malliaras K, Makkar RR, Smith RR, Cheng K, Wu E, Bonow RO, et al. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol. 2014; 63(2):110-122. https://doi.org/10.1016/j.jacc.2013.08.724 PMid:24036024 PMCid:PMC3947063

110. Mann I, Rodrigo SF, van Ramshorst J, Beeres SL, Dibbets-Schneider P, de Roos A, et al. Repeated intramyocardial bone marrow cell injection in previously responding patients with refractory angina again improves myocardial perfusion, anginal complaints, and quality of life. Circ Cardiovasc Interv. 2015;8:e002740. Available from: https://doi.org/10.1161/circinterventions.115.002740 https://doi.org/10.1161/CIRCINTERVENTIONS.115.002740 PMid:26259770

111. Martino H, Brofman P, Greco O, Bueno R, Bodanese L, Clausell N, et al. Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study) Eur Heart J. 2015;36:2898-904. Available from: https://doi.org/10.1093/eurheartj/ehv477 https://doi.org/10.1093/eurheartj/ehv477 PMid:26392433

112. Mathiasen AB, Jørgensen E, Qayyum AA, Haack-Sørensen M, Ekblond A, Kastrup J. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial). Am Heart J. 2012;164(3):285-91. Available from: https://doi.org/10.1016/j.ahj.2012.05.026 https://doi.org/10.1016/j.ahj.2012.05.026 PMid:22980293

113. McCall FC, Telukuntla KS, Karantalis V, Suncion VY, Heldman AW, Mushtaq M, et al. Myocardial infarction and intramyocardial injection models in swine. Nat Protoc. 2012; 7(8):1479-96. Available from: http://doi.org/10.1038/nprot.2012.075 https://doi.org/10.1038/nprot.2012.075 PMid:22790084 PMCid:PMC3936356

114. Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation. 2008; 117(9):1189-200. Available from: http://doi.org/10.1161/circulationaha.107.734103 https://doi.org/10.1161/CIRCULATIONAHA.107.734103 PMid:18285565

115. Menasché P, Hagège AA, Scorsin M, Pouzet B, Desnos M, Duboc D, et al. Myoblast transplantation for heart failure. Lancet. 2001; 357(9252):279-280. Available from: http://doi.org/10.1016/S0140-6736(00)03617-5. PMID: 11214133 https://doi.org/10.1016/S0140-6736(00)03617-5 PMid:11214133

116. Menasché P, Vanneaux V, Hagège A, Bel A, Cholley B, Parouchev A, et al. Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction. J Am Coll Cardiol. 2018 Jan 30;71(4):429-438. Available from: https://doi.org/10.1016/j.jacc.2017.11.047 https://doi.org/10.1016/j.jacc.2017.11.047 PMid:29389360

117. Menasché P. Cell Therapy With Human ESC-Derived Cardiac Cells: Clinical Perspectives. Front Bioeng Biotechnol. 2020 Oct 26;8:601560. Available from: https://doi.org/10.3389/fbioe.2020.601560 https://doi.org/10.3389/fbioe.2020.601560 PMid:33195177 PMCid:PMC7649799

118. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004; 95(9):911-921. Available from: https://doi.org/10.1161/01.res.0000147315.71699.51 https://doi.org/10.1161/01.RES.0000147315.71699.51 PMid:15472116

119. Miranville A, Heeschen C, Sengenès C, Curat CA, Busse R, Bouloumié A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation. 2004; 110(3):349-355. Available from: https://doi.org/10.1161/01.cir.0000135466.16823.d0 https://doi.org/10.1161/01.CIR.0000135466.16823.D0 PMid:15238461

120. Mishra R, Vijayan K, Colletti EJ, Harrington DA, Matthiesen TS, Simpson D, et al. Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation. 2011; 123(4):364-373. Available from: https://doi.org/10.1161/circulationaha.110.971622 https://doi.org/10.1161/CIRCULATIONAHA.110.971622 PMid:21242485 PMCid:PMC3320857

121. Miyagawa S, Kainuma S, Kawamura T, Suzuki K, Ito Y, Iseoka H, Iet al. Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy. Front Cardiovasc Med. 2022 Aug 16;9:950829. Available from: https://doi.org/10.3389/fcvm.2022.950829 https://doi.org/10.3389/fcvm.2022.950829 PMid:36051285 PMCid:PMC9426776

122. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004 Apr 8;428(6983):664-8. Available from: https://doi.org/10.1038/nature02446 https://doi.org/10.1038/nature02446 PMid:15034593

123. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest. 1996; 98(11):2512-2523. Available from: https://doi.org/10.1172/jci119070 https://doi.org/10.1172/JCI119070 PMid:8958214 PMCid:PMC507709

124. Nakamura K, Murry CE. Function follows form – a review of cardiac cell therapy. Circ J. 2019 Nov 25;83(12):2399-2412. Available from: https://doi.org/10.1253/circj.CJ-19-0567 https://doi.org/10.1253/circj.CJ-19-0567 PMid:31723070 PMCid:PMC7002039

125. Natsumeda M, Florea V, Rieger AC, Tompkins BA, Banerjee MN, Golpanian S, et al. A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration. J Am Coll Cardiol. 2017 Nov 14;70(20):2504-2515. Available from: https://doi.org/10.1016/j.jacc.2017.09.036 https://doi.org/10.1016/j.jacc.2017.09.036 PMid:29145950 PMCid:PMC5796680

126. Nowacki M, Kloskowski T, Pietkun K, Zegarski M, Pokrywczyńska M, Habib SL, et al. The use of stem cells in aesthetic dermatology and plastic surgery procedures. A compact review of experimental and clinical applications. Postepy Dermatol Alergol. 2017;34(6):526-534. Available from: https://doi.org/10.5114/ada.2017.72456 https://doi.org/10.5114/ada.2017.72456 PMid:29422816 PMCid:PMC5799755

127. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A. 2003; 100(21):12313-12318. Available from: https://doi.org/10.1073/pnas.2132126100 https://doi.org/10.1073/pnas.2132126100 PMid:14530411 PMCid:PMC218755

128. Okano S, Shiba Y. Therapeutic Potential of Pluripotent Stem Cells for Cardiac Repair after Myocardial Infarction. Biol Pharm Bull. 2019;42(4):524-530. Available from: https://doi.org/10.1248/bpb.b18-00257 https://doi.org/10.1248/bpb.b18-00257 PMid:30930411

129. Okura H, Saga A, Soeda M, Miyagawa S, Sawa Y, Daimon T, et al. Intracoronary artery transplantation of cardiomyoblast-like cells from human adipose tissue-derived multi-lineage progenitor cells improve left ventricular dysfunction and survival in a swine model of chronic myocardial infarction. Biochem Biophys Res Commun. 2012. 425(4):859-65. Available from: https://doi.org/10.1016/j.bbrc.2012.08.004 https://doi.org/10.1016/j.bbrc.2012.08.004 PMid:22898045

130. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A. 2001; 98(18):10344-10349. Available from: https://doi.org/10.1073/pnas.181177898 https://doi.org/10.1073/pnas.181177898 PMid:11504914 PMCid:PMC56963

131. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, et al.Bone marrow cells regenerate infarcted myocardium. Nature. 2001 Apr 5;410(6829):701-5. Available from: https://doi.org/10.1038/35070587 https://doi.org/10.1038/35070587 PMid:11287958

132. Oskouei BN, Lamirault G, Joseph C, Treuer AV, Landa S, Da Silva J, et al. Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair. Stem Cells Transl Med. 2012;1(2):116-24. Available from: https://doi.org/10.5966/sctm.2011-0015 https://doi.org/10.5966/sctm.2011-0015 PMid:23197758 PMCid:PMC3659683

133. Ostovaneh MR, Makkar RR, Ambale-Venkatesh B, Ascheim D, Chakravarty T, Henry TD, et al. Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial. Open Heart. 2021 Jul;8(2):e001614. Available from: https://doi.org/10.1136/openhrt-2021-001614 https://doi.org/10.1136/openhrt-2021-001614 PMid:34233913 PMCid:PMC8264869

134. Palpant NJ, Yasuda S, MacDougald O, Metzger JM. Non-canonical Wnt signaling enhances differentiation of Sca1+/c-kit+ adipose-derived murine stromal vascular cells into spontaneously beating cardiac myocytes. J Mol Cell Cardiol. 2007 Sep;43(3):362-70. doi: 10.1016/j.yjmcc.2007.06.012 https://doi.org/10.1016/j.yjmcc.2007.06.012 PMid:17706246 PMCid:PMC2048991

135. Parolini O, Alviano F, Bagnara GP, Bilic G, Bühring HJ, Evangelista M, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells. 2008; 26:300-311. Available from: https://doi.org/10.1634/stemcells.2007-0594 https://doi.org/10.1634/stemcells.2007-0594 PMid:17975221

136. Passipieri JA, Kasai-Brunswick TH, Suhett G, Martins AB, Brasil GV, Campos DB, et al. Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway. Stem Cell Res Ther. 2014 Aug 21;5(4):102. Available from: https://doi.org/10.1186/scrt490 https://doi.org/10.1186/scrt490 PMid:25145631 PMCid:PMC4354978

137. Patel AN, Henry TD, Quyyumi AA, Schaer GL, Anderson RD, Toma C, et al. Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial. Lancet. 2016 Jun 11;387(10036):2412-21. Available from: https://doi.org/10.1016/S0140-6736(16)30137-4 https://doi.org/10.1016/S0140-6736(16)30137-4 PMid:27059887

138. Perin EC, Sanz-Ruiz R, Sánchez PL, Lasso J, Pérez-Cano R, Alonso-Farto JC, et al. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial. Am Heart J. 2014;168(1):88-95.e2. Available from: http://doi.org/10.1016/j.ahj.2014.03.022 https://doi.org/10.1016/j.ahj.2014.03.022 PMid:24952864

139. Perin EC, Silva GV, Assad JA, Vela D, Buja LM, Sousa AL, et al. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol. 2008; 44(3):486-495. Available from: https://doi.org/10.1016/j.yjmcc.2007.09.012 https://doi.org/10.1016/j.yjmcc.2007.09.012 PMid:18061611

140. Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, et al. Cardiovascular Cell Therapy Research Network (CCTRN). Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA. 2012 Apr 25;307(16):1717-26. Available from: https://doi.org/10.1001/jama.2012.418 https://doi.org/10.1001/jama.2012.418 PMid:22447880 PMCid:PMC3600947

141. Planat-Bénard V, Menard C, André M, Puceat M, Perez A, Garcia-Verdugo JM, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res. 2004; 94(2):223-229. Available from: https://doi.org/10.1161/01.res.0000109792.43271.47 https://doi.org/10.1161/01.RES.0000109792.43271.47 PMid:14656930

142. Puymirat E, Geha R, Tomescot A, Bellamy V, Larghero J, Trinquart L, et al. Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells? Mol Ther. 2009 Jan;17(1):176-82. Available from: https://doi.org/10.1038/mt.2008.208 https://doi.org/10.1038/mt.2008.208 PMid:18841094 PMCid:PMC2834983

143. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A. 2009; 106(33):14022-14027. Available from: https://doi.org/10.1073/pnas.0903201106 https://doi.org/10.1073/pnas.0903201106 PMid:19666564 PMCid:PMC2729013

144. Quijada P, Salunga HT, Hariharan N, Cubillo JD, El-Sayed FG, Moshref M, et al. Cardiac stem cell hybrids enhance myocardial repair. Circ Res. 2015; 117(8):695-706. https://doi.org/10.1161/CIRCRESAHA.115.306838 PMid:26228030 PMCid:PMC4583815

145. Reich H, Tseliou E, de Couto G, Angert D, Valle J, Kubota Y, et al. Repeated transplantation of allogeneic cardiosphere-derived cells boosts therapeutic benefits without immune sensitization in a rat model of myocardial infarction. J Heart Lung Transplant. 2016;35(11):1348-1357. Available from: https://doi.org/10.1016/j.healun.2016.05.008 https://doi.org/10.1016/j.healun.2016.05.008 PMid:27342903

146. Richardson JD, Psaltis PJ, Frost L, Paton S, Carbone A, Bertaso AG, et al. Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction. Cytotherapy. 2014;16(4):460-70. Available from: https://doi.org/10.1016/j.jcyt.2013.07.016 https://doi.org/10.1016/j.jcyt.2013.07.016 PMid:24113430

147. Rubart M, Soonpaa MH, Nakajima H, Field LJ. Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest. 2004; 114(6):775-783. Available from: https://doi.org/10.1172/jci21589 https://doi.org/10.1172/JCI21589 PMid:15372101 PMCid:PMC516262

148. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006; 355(12):1210-1021. Available from: https://doi.org/10.1056/nejmoa060186 https://doi.org/10.1056/NEJMoa060186 PMid:16990384

149. Schuleri KH, Feigenbaum GS, Centola M, Weiss ES, Zimmet JM, Turney J, et al. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J. 2009; 30(22):2722-2732. Available from: https://doi.org/10.1093/eurheartj/ehp265 https://doi.org/10.1093/eurheartj/ehp265 PMid:19586959 PMCid:PMC2777027

150. Scorsin M, Hagège A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg. 2000; 119(6):1169-1175. Available from: https://doi.org/10.1067/mtc.2000.104865 https://doi.org/10.1067/mtc.2000.104865 PMid:10838534

151. Sheng CC, Zhou L, Hao J. Current stem cell delivery methods for myocardial repair. Biomed Res Int. 2013;2013:547902. Available from: https://doi.org/10.1155/2013/547902 https://doi.org/10.1155/2013/547902 PMid:23509740 PMCid:PMC3591183

152. Shirbaghaee Z, Heidari Keshel S, Rasouli M, Valizadeh M, Hashemi Nazari SS, et al. Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI). Stem Cell Res Ther. 2023 Jul 5;14(1):174. Available from: https://doi.org/10.1186/s13287-023-03390-9 https://doi.org/10.1186/s13287-023-03390-9 PMid:37408043 PMCid:PMC10324209

153. Shudo Y, Miyagawa S, Ohkura H, Fukushima S, Saito A, Kawaguchi N, et al. Adipose tissue-derived multi-lineage progenitor cells improve left ventricular dysfunction in porcine ischemic cardiomyopathy model. J Heart Lung Transplant. 2017; 36(2):237-239. Available from: https://doi.org/10.1016/j.healun.2016.11.012 https://doi.org/10.1016/j.healun.2016.11.012 PMid:28159019

154. Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Rozwadowska N, Kałmucki P, Kurpisz M. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J. 2005 Jun;26(12):1188-95. Available from: https://doi.org/10.1093/eurheartj/ehi159 https://doi.org/10.1093/eurheartj/ehi159 PMid:15764613

155. Simioniuc A, Campan M, Lionetti V, Marinelli M, Aquaro GD, Cavallini C, et al. Placental stem cells pre-treated with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig hearts: a multimodal study. Cardiovasc Res. 2011;90(3):546-56. Available from: https://doi.org/10.1093/cvr/cvr018 https://doi.org/10.1093/cvr/cvr018 PMid:21257613

156. Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007; 115(7):896-908. Available from: https://doi.org/10.1161/circulationaha.106.655209 https://doi.org/10.1161/CIRCULATIONAHA.106.655209 PMid:17283259

157. Sokol A, Grekov D, Yemets G, Galkin A, Shchotkina N, Dovghaliuk A, Rudenko N, Yemets I. The Efficiency of Decellularization of Bovine Pericardium by Different Concentrations of Sodium Dodecyl Sulfate. Innov Biosyst Bioeng. 2020;4(4):189-98. https://doi.org/10.20535/ibb.2020.4.4.214765

158. Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant. 2016;25(5):829-48. Available from: https://doi.org/10.3727/096368915X689622 https://doi.org/10.3727/096368915X689622 PMid:26423725

159. Strauer BE, Brehm M, Zeus T, Köstering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002; 106(15):1913-1918. Available from: https://doi.org/10.1161/01.cir.0000034046.87607.1c https://doi.org/10.1161/01.CIR.0000034046.87607.1C PMid:12370212

160. Suss PH, Capriglione LG, Barchiki F, Miyague L, Jackowski D, Fracaro L, et al. Direct intracardiac injection of umbilical cord-derived stromal cells and umbilical cord blood-derived endothelial cells for the treatment of ischemic cardiomyopathy. Exp Biol Med (Maywood). 2015 Jul;240(7):969-78. Available from: https://doi.org/10.1177/1535370214565077 https://doi.org/10.1177/1535370214565077 PMid:25576340 PMCid:PMC4935404

161. Suuronen EJ, Price J, Veinot JP, Ascah K, Kapila V, Guo XW, et al. Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function. J Thorac Cardiovasc Surg. 2007 Nov;134(5):1249-58. Available from: https://doi.org/10.1016/j.jtcvs.2007.07.028 https://doi.org/10.1016/j.jtcvs.2007.07.028 PMid:17976457

162. Szaraz P, Gratch YS, Iqbal F, Librach CL. In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells. J Vis Exp. 2017 Aug 9;(126):55757. Available from: https://doi.org/10.3791/557573 https://doi.org/10.3791/55757

163. Takehara N, Nagata M, Ogata T, Kami D, Nakamura T, Matoba S, et al. The ALCADIA (Autologous Human Cardiac-derived Stem Cell To Treat Ischemic Cardiomyopathy) trial. 2012; Circulation. 126:2776-2799. Available from: https://doi.org/10.1161/CIR.0b013e318278c90d https://doi.org/10.1161/CIR.0b013e318278c90d

164. Tarui S, Ishigami S, Ousaka D, Kasahara S, Ohtsuki S, Sano S, et al. Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the transcoronary infusion of cardiac progenitor cells in patients with single-ventricle physiology (TICAP) trial. J Thorac Cardiovasc Surg. 2015;150(5):1198-1207, 1208.e1-2. Available from: https://doi.org/10.1016/j.jtcvs.2015.06.076 https://doi.org/10.1016/j.jtcvs.2015.06.076 PMid:26232942

165. Tateishi K, Ashihara E, Honsho S, Takehara N, Nomura T, Takahashi T, et al. Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3beta signaling. Biochem Biophys Res Commun. 2007; 352(3):635-641. Available from: https://doi.org/10.1016/j.bbrc.2006.11.096 https://doi.org/10.1016/j.bbrc.2006.11.096 PMid:17150190

166. Tateishi K, Ashihara E, Takehara N, Nomura T, Honsho S, Nakagami T, et al. Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration. J Cell Sci. 2007; 120(Pt 10):1791-1800. Available from: https://doi.org/10.1242/jcs.006122 https://doi.org/10.1242/jcs.006122 PMid:17502484

167. Tateishi K, Takehara N, Matsubara H, Oh H. Stemming heart failure with cardiac- or reprogrammed-stem cells. J Cell Mol Med. 2008; 12(6A):2217-2232. Available from: https://doi.org/10.1111/j.1582-4934.2008.00487.x https://doi.org/10.1111/j.1582-4934.2008.00487.x PMid:18754813 PMCid:PMC4514101

168. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 1998; 4(8):929-933. Available from: https://doi.org/10.1038/nm0898-929 https://doi.org/10.1038/nm0898-929 PMid:9701245

169. Terajima Y, Shimizu T, Tsuruyama S, Sekine H, Ishii H, Yamazaki K, et al. Autologous skeletal myoblast sheet therapy for porcine myocardial infarction without increasing risk of arrhythmia. Cell Med. 2013; 6(3):99-109. Available from: http://doi.org/10.3727/215517913X672254 https://doi.org/10.3727/215517913X672254 PMid:26858886 PMCid:PMC4733831

170. Thompson CA, Nasseri BA, Makower J, Houser S, McGarry M, Lamson T, et al. Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol. 2003 Jun 4;41(11):1964-71. Available from: https://doi.org/10.1016/s0735-1097(03)00397-8 https://doi.org/10.1016/S0735-1097(03)00397-8 PMid:12798567

171. Tiburcy M, Hudson JE, Balfanz P, Schlick S, Meyer T, Chang Liao ML, et al. Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair. Circulation. 2017 May 9;135(19):1832-1847. Available from: https://doi.org/10.1161/CIRCULATIONAHA.116.024145 https://doi.org/10.1161/CIRCULATIONAHA.116.024145 PMid:28167635 PMCid:PMC5501412

172. Tokita Y, Tang XL, Li Q, Wysoczynski M, Hong KU, Nakamura S, et al. Repeated administrations of cardiac progenitor cells are markedly more effective than a single administration: a new paradigm in cell therapy. Circ Res. 2016;119(5):635-51. Available from: https://doi.org/10.1161/CIRCRESAHA.116.308937 https://doi.org/10.1161/CIRCRESAHA.116.308937 PMid:27364016 PMCid:PMC4992406

173. Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA. 2011; 306(19):2110-2119. Available from: https://doi.org/10.1001/jama.2011.1670 https://doi.org/10.1001/jama.2011.1670 PMid:22084195 PMCid:PMC3600981

174. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Zhao DX, Ellis SG, et al. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA. 2012; 308(22):2380-2389. Available from: https://doi.org/10.1001/jama.2012.28726 https://doi.org/10.1001/jama.2012.28726 PMid:23129008 PMCid:PMC3652242

175. Turner D, Rieger AC, Balkan W, Hare JM. Clinical-based Cell Therapies for Heart Disease-Current and Future State. Rambam Maimonides Med J. 2020 Apr 29;11(2):e0015. Available from: https://doi.org/10.5041/RMMJ.10401 https://doi.org/10.5041/RMMJ.10401 PMid:32374254 PMCid:PMC7202446

176. Vadakke-Madathil S, LaRocca G, Raedschelders K, Yoon J, Parker SJ, Tripodi J, et al. Multipotent fetal-derived Cdx2 cells from placenta regenerate the heart. Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11786-11795. Available from: https://doi.org/10.1073/pnas.1811827116 https://doi.org/10.1073/pnas.1811827116 PMid:31109997 PMCid:PMC6576083

177. Valina C, Pinkernell K, Song YH, Bai X, Sadat S, Campeau RJ, Le Jemtel TH, Alt E. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J. 2007 Nov;28(21):2667-77. doi: 10.1093/eurheartj/ehm426 https://doi.org/10.1093/eurheartj/ehm426 PMid:17933755

178. van Berlo JH, Kanisicak O, Maillet M, Vagnozzi RJ, Karch J, Lin SC, et al. c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 509, 337-341 (2014). Available from: https://doi.org/10.1038/nature13309 https://doi.org/10.1038/nature13309 PMid:24805242 PMCid:PMC4127035

179. Ventura C, Cantoni S, Bianchi F, Lionetti V, Cavallini C, Scarlata I, et al. Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. J Biol Chem. 2007; 282:14243-14252. Available from: https://doi.org/10.1074/jbc.m609350200 https://doi.org/10.1074/jbc.M609350200 PMid:17363374

180. Wang L, Deng J, Tian W, Xiang B, Yang T, Li G, et al. Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. Am J Physiol Heart Circ Physiol. 2009; 297(3):H1020-31. Available from: http://doi.org/10.1152/ajpheart.01082.2008 https://doi.org/10.1152/ajpheart.01082.2008 PMid:19574490

181. Wang T, Tang W, Sun S, Ristagno G, Huang Z, Weil MH. Intravenous infusion of bone marrow mesenchymal stem cells improves myocardial function in a rat model of myocardial ischemia. Crit Care Med. 2007; 35(11):2587-2593. Available from: https://doi.org/10.1097/01.ccm.0000285992.99391.7e https://doi.org/10.1097/01.CCM.0000285992.99391.7E PMid:17828039

182. Ward MR, Abadeh A, Connelly KA. Concise Review: Rational Use of Mesenchymal Stem Cells in the Treatment of Ischemic Heart Disease. Stem Cells Transl Med. 2018 Jul;7(7):543-550. Available from: https://doi.org/10.1002/sctm.17-0210 https://doi.org/10.1002/sctm.17-0210 PMid:29665255 PMCid:PMC6052612

183. White AJ, Smith RR, Matsushita S, Chakravarty T, Czer LS, Burton K, et al. Intrinsic cardiac origin of human cardiosphere-derived cells. European Heart Journal. 2013; 34:68-75. Available from: https://doi.org/10.1093/eurheartj/ehr172 https://doi.org/10.1093/eurheartj/ehr172 PMid:21659438

184. Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, et al. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation. 2013;127(2):213-23. Available from: https://doi.org/10.1161/CIRCULATIONAHA.112.131110 https://doi.org/10.1161/CIRCULATIONAHA.112.131110 PMid:23224061 PMCid:PMC3579523

185. Windmolders S, Willems L, Daniëls A, Linsen L, Fanton Y, Hendrikx M, et al. Clinical-scale in vitro expansion preserves biological characteristics of cardiac atrial appendage stem cells. Cell Prolif. 2015; 48(2):175-86. Available from: https://doi.org/10.1111/cpr.12166 https://doi.org/10.1111/cpr.12166 PMid:25630660 PMCid:PMC6495491

186. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004; 364(9429):141-148. Available from: https://doi.org/10.1016/s0140-6736(04)16626-9 https://doi.org/10.1016/S0140-6736(04)16626-9 PMid:15246726

187. Wu M, Zhang R, Zou Q, Chen Y, Zhou M, Li X, et al. Comparison of the biological characteristics of mesenchymal stem cells derived from the human placenta and umbilical cord. Sci Rep. 2018 Mar 22;8(1):5014. Available from: https://doi.org/10.1038/s41598-018-23396-1 https://doi.org/10.1038/s41598-018-23396-1 PMid:29568084 PMCid:PMC5864926

188. Wu S, Duan B, Qin X, Butcher JT. Living nano-micro fibrous woven fabric/hydrogel composite scaffolds for heart valve engineering. Acta Biomater. 2017. 51:89-100. Available from: http://doi.org/10.1016/j.actbio.2017.01.051 https://doi.org/10.1016/j.actbio.2017.01.051 PMid:28110071

189. Yacoub MH, Terrovitis J. CADUCEUS, SCIPIO, ALCADIA: Cell therapy trials using cardiac-derived cells for patients with post myocardial infarction LV dysfunction, still evolving. Glob Cardiol Sci Pract. 2013;2013(1):5-8. Available from: https://doi.org/10.5339/gcsp.2013.3 https://doi.org/10.5339/gcsp.2013.3 PMid:24688997 PMCid:PMC3963730

190. Yadav SK, Mishra PK. Isolation, characterization, and differentiation of cardiac stem cells from the adult mouse heart. J Vis Exp. 2019; 143:10.3791/58448. Available from: https://doi.org/10.3791/58448 https://doi.org/10.3791/58448 PMCid:PMC7207148

191. Yamada Y, Yokoyama S, Fukuda N, Kidoya H, Huang XY, Naitoh H, et al. A novel approach for myocardial regeneration with educated cord blood cells cocultured with cells from brown adipose tissue. Biochem Biophys Res Commun. 2007 Feb 2;353(1):182-8. doi: 10.1016/j.bbrc.2006.12.017. https://doi.org/10.1016/j.bbrc.2006.12.017 PMid:17174277

192. Yamaguchi S, Shimizu Y, Murohara T, Shibata R. Adipose-derived regenerative cells as a promising therapy for cardiovascular diseases: an overview. Nagoya J Med Sci. 2022 May;84(2):208-215. Available from: https://doi.org/10.18999/nagjms.84.2.208

193. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell. 2007;1(1):39-49. Available from: https://doi.org/10.1016/j.stem.2007.05.012 https://doi.org/10.1016/j.stem.2007.05.012 PMid:18371333

194. Yang CJ, Yang J, Yang J, Fan ZX. Cardiac atrial appendage stem cells therapy: a novel and promising approach for myocardial reparation after MI. Int J Cardiol. 2016; 203:1153-4. Available from: https://doi.org/10.1016/j.ijcard.2015.10.039 https://doi.org/10.1016/j.ijcard.2015.10.039 PMid:26478524

195. Yannarelli G, Dayan V, Pacienza N, Lee CJ, Medin J, Keating A. Human umbilical cord perivascular cells exhibit enhanced cardiomyocyte reprogramming and cardiac function after experimental acute myocardial infarction. Cell Transplant. 2013;22(9):1651-66. Available from: https://doi.org/10.3727/096368912X657675 https://doi.org/10.3727/096368912X657675 PMid:23043977

196. Yap L, Chong LY, Tan C, Adusumalli S, Seow M, Guo J, et al. Pluripotent stem cell-derived committed cardiac progenitors remuscularize damaged ischemic hearts and improve their function in pigs. NPJ Regen Med. 2023 May 26;8(1):26. Available from: https://doi.org/10.1038/s41536-023-00302-6 https://doi.org/10.1038/s41536-023-00302-6 PMid:37236990 PMCid:PMC10219927

197. Yee K, Malliaras K, Kanazawa H, Tseliou E, Cheng K, Luthringer DJ, et al. Allogeneic cardiospheres delivered via percutaneous transendocardial injection increase viable myocardium, decrease scar size, and attenuate cardiac dilatation in porcine ischemic cardiomyopathy. PLoS One. 2014;9(12):e113805. Available from: https://doi.org/10.1371/journal.pone.0113805 https://doi.org/10.1371/journal.pone.0113805 PMid:25460005 PMCid:PMC4251970

198. Yu Q, Li Q, Na R, Li X, Liu B, Meng L, et al. Impact of repeated intravenous bone marrow mesenchymal stem cells infusion on myocardial collagen network remodeling in a rat model of doxorubicin-induced dilated cardiomyopathy. Mol Cell Biochem. 2014; 387(1-2):279-285. Available from: https://doi.org/10.1007/s11010-013-1894-1 https://doi.org/10.1007/s11010-013-1894-1 PMid:24257807

199. Yu S, You X, Liang H, Li Y, Fu Y, Zhang X, et al. First trimester placental mesenchymal stem cells improve cardiac function of rat after myocardial infarction via enhanced neovascularization. Heliyon. 2021; 7(1):e06120. Available from: https://doi.org/10.1016/j.heliyon.2021.e06120 https://doi.org/10.1016/j.heliyon.2021.e06120 PMid:33553765 PMCid:PMC7855719

200. Zhang J, Tao R, Lalit P, Carvalho J, Markandeya Y, Palecek S, et al. Cardiac differentiation of human pluripotent stem cells using defined extracellular matrix proteins reveals essential role of fibronectin. bioRxiv. 2021. Available from: https://doi.org/10.1101/2021.04.09.439173 https://doi.org/10.1101/2021.04.09.439173

201. Zhang S, Jia Z, Ge J, Gong L, Ma Y, Li T, et al. Purified human bone marrow multipotent mesenchymal stem cells regenerate infarcted myocardium in experimental rats. Cell Transplant. 2005; 14(10):787-798. Available from: https://doi.org/10.3727/000000005783982558 https://doi.org/10.3727/000000005783982558 PMid:16454353

202. Zhang X, Wei M, Zhu W, Han B. Combined transplantation of endothelial progenitor cells and mesenchymal stem cells into a rat model of isoproterenol-induced myocardial injury. Arch Cardiovasc Dis. 2008 May;101(5):333-42. Available from: https://doi.org/10.1016/j.acvd.2008.05.002 https://doi.org/10.1016/j.acvd.2008.05.002 PMid:18656092

203. Zhao L, Chen S, Yang P, Cao H, Li L. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease. Stem Cell Res Ther. 2019;10(1):182. Available from: https://doi.org/10.1186/s13287-019-1287-9 https://doi.org/10.1186/s13287-019-1287-9 PMid:31227011 PMCid:PMC6588914

204. Zhao XF, Xu Y, Zhu ZY, Gao CY, Shi YN. Clinical observation of umbilical cord mesenchymal stem cell treatment of severe systolic heart failure. Genet Mol Res. 2015 Apr 10;14(2):3010-7. Available from: https://doi.org/10.4238/2015.April.10.11 https://doi.org/10.4238/2015.April.10.11 PMid:25966065

205. Zhu Y, Liu T, Ye H, Song K, Ma X, Cui Z. Enhancement of adipose-derived stem cell differentiation in scaffolds with IGF-I gene impregnation under dynamic microenvironment. Stem Cells Dev. 2010 Oct;19(10):1547-56. doi: 10.1089/scd.2010.0054 https://doi.org/10.1089/scd.2010.0054 PMid:20408758

206. Zwetsloot PP, Végh AM, Jansen of Lorkeers SJ, van Hout GP, Currie GL, Sena ES, et al. Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies. Circ Res. 2016;118(8):1223-32. Available from: https://doi.org/10.1161/CIRCRESAHA.115.307676 https://doi.org/10.1161/CIRCRESAHA.115.307676 PMid:26888636

How to cite

Kyryk V. Stem cell therapy for cardiac regeneration: key points. Cell Organ Transpl. 2024; 12(1):4-21. Available from: https://doi.org/10.22494/cot.v12i1.160

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.